← Latest Filings

K

Keller Eric L.

CHIEF EXECUTIVE OFFICER

Open-market buys

1

$250K total

Open-market sells

0

$0 total

Tracking since

Oct 2026

Activity timeline

Open-market buy — $250K

Retension Pharmaceuticals, Inc. · Oct 13, 2026

Open-market trades from the last two years.

Holdings as last reported

464,407 Common Stock in RTSN

Held directly · as of 2026-10-13

255,174 Stock Option (right to buy) in RTSN

Held directly · as of 2026-10-13

Companies touched

Retension Pharmaceuticals, Inc.